---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-037350"
form_type: "8-K"
ticker: "PVLA"
cik: "0001583648"
company_name: "PALVELLA THERAPEUTICS, INC."
filed_at: "2024-12-12T23:59:59+00:00"
generated_at: "2026-05-29T04:05:44.726267+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Stockholders approve merger with Palvella; authorized shares increased 53x to 200M

## Summary
- Merger expected to close Dec. 13; pre-merger stockholders receive Contingent Value Rights.
- Authorized shares increased from 3.75M to 200M; Series F Preferred redeemed for $0.01.
- Proposal to issue shares in merger approved: 718,345 for, 4,199 against, 294,890 broker non-votes.
- Name change to Palvella Therapeutics, Inc. and 2024 Equity Incentive Plan approved.
- All proposals approved by requisite votes; no adjournment needed.

## SEC filing metadata
- accession: 0001437749-24-037350
- form_type: 8-K
- ticker: PVLA
- cik: 0001583648
- company_name: PALVELLA THERAPEUTICS, INC.
- filed_at: 2024-12-12T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.03, 5.07, 5.02, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1583648/000143774924037350/0001437749-24-037350-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1583648/000143774924037350/pirs20241115c_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-037350
- JSON: https://secwatch.observer/filing/0001437749-24-037350.json
- Plain text: https://secwatch.observer/filing/0001437749-24-037350.txt

## Key facts
- Governance Changes
  PALVELLA THERAPEUTICS, INC.: Increased authorized shares of common stock from 3,750,000 to 200,000,000 (effective 2024-12-12).
  - Change: charter amendment
  - Effective: 2024-12-12
  source text: At the Special Meeting, the Company’s stockholders approved an amendment to the amended and restated articles of incorporation of the Company (the “Authorized Share Increase Amendment”) to implement an increase in the number of authorized shares of common stock from 3,750,000 to 200,000,000 (the “Share Increase”). On December 12, 2024, the Company filed the Share Increase Amendment with the Nevada Secretary of State to effect the Share Increase effective on December 12, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1583648/000143774924037350/0001437749-24-037350-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.